Zhi Tong Cai Jing·2026-01-28 03:26Core Viewpoint - Alibaba Health's stock rose nearly 4%, reaching HKD 6.92 with a trading volume of HKD 506 million, following the launch of its AI medical application "Hydrogen Ion" with a new feature for "dynamic evidence positioning" [1] Group 1: Product Development - The "Hydrogen Ion" application now includes a feature that accurately identifies specific statements in original texts, verifying their timeliness, authority, and logical consistency [1] - This upgrade enhances the previous method of vague citations in AI responses to a precise identification of statements and their credibility [1] - The product has completed internal testing and is now available for download, targeting doctors in clinical and research fields [1] Group 2: Market Position and Outlook - CITIC Securities highlights that leading pharmaceutical e-commerce platforms, including Alibaba Health and JD Health, have launched AI medical applications aimed at doctors [1] - The report expresses optimism about these platforms leveraging resources from upstream pharmaceutical companies and downstream end-users, along with their parent companies' AI capabilities, to excel in the ToD AI medical application sector [1] - The expectation is that these companies will successfully establish a commercial model that enhances revenue through AI medical applications [1]